Evidence map›Paper›PMID 30342156›Full record

ArticleBiochimica et biophysica acta. General subjects2019

Catechin-mediated restructuring of a bacterial toxin inhibits activity.

En Hyung Chang, Joanne Huang, Zixiang Lin, Angela C Brown

Abstract read
In one paragraph

Article in Biochimica et biophysica acta. General subjects, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 48 citations in OpenAlex.

  1. Mechanistic Insights into the Anti-Virulence Effects ofAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Antibacterial and Synergistic Effects ofAntibiotics (Basel, Switzerland) · 2025
    Article
  6. Green Tea: Current Knowledge and Issues.Foods (Basel, Switzerland) · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Potential of phenolic compounds from pomegranate (Saudi journal of biological sciences · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Aggregatibacter actinomycetemcomitans: From Basic to Advanced Research.Advances in experimental medicine and biology · 2022
    Article
  19. Matcha Green Tea Exhibits Bactericidal Activity againstAntibiotics (Basel, Switzerland) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

En Hyung ChangDepartment of Chemical and Biomolecular Engineering, Lehigh University, Bethlehem, PA 18015, USA.
Joanne HuangDepartment of Chemical and Biomolecular Engineering, Lehigh University, Bethlehem, PA 18015, USA.
Zixiang LinDepartment of Chemical and Biomolecular Engineering, Lehigh University, Bethlehem, PA 18015, USA.
Angela C BrownDepartment of Chemical and Biomolecular Engineering, Lehigh University, Bethlehem, PA 18015, USA. Electronic address: acb313@lehigh.edu.
Lehigh University · US

Funding

Cytotoxic mechanisms of Aggregatibacter actinomycetemcomitans leukotoxinR00DE022795 · NIDCR · LEHIGH UNIVERSITY · PI BROWN, ANGELA C. · 2014 to 2016
$838k
Mechanism of A. actinomycetemcomitans Outer Membrane Vesicle Delivery to Target CellsR03DE025275 · NIDCR · LEHIGH UNIVERSITY · PI BROWN, ANGELA C. · 2016 to 2017
$226k
Cytotoxic mechanisms of Aggregatibacter actinomycetemcomitans leukotoxinK99DE022795 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI BROWN, ANGELA C. · 2012 to 2013
$155k
NIDCR NIH HHS K99 DE022795NIDCR NIH HHS R00 DE022795NIDCR NIH HHS R03 DE025275
6 · The paper itself

Abstract

backgroundCatechins, polyphenols derived from tea leaves, have been shown to have antibacterial properties, through direct killing of bacteria as well as through inhibition of bacterial toxin activity. In particular, certain catechins have been shown to have bactericidal effects on the oral bacterium, Aggregatibacter actinomycetemcomitans, as well as the ability to inhibit a key virulence factor of this organism, leukotoxin (LtxA). The mechanism of catechin-mediated inhibition of LtxA has not been shown.

methodsIn this work, we studied the ability of six catechins to inhibit LtxA-mediated cytotoxicity in human white blood cells, using Trypan blue staining, and investigated the mechanism of action using a combination of techniques, including fluorescence and circular dichroism spectroscopy, confocal microscopy, and surface plasmon resonance.

resultsWe found that all the catechins except (-)-catechin inhibited the activity of this protein, with the galloylated catechins having the strongest effect. Pre-incubation of the toxin with the catechins increased the inhibitory action, indicating that the catechins act on the protein, rather than the cell. The secondary structure of LtxA was dramatically altered in the presence of catechin, which resulted in an inhibition of toxin binding to cholesterol, an important initial step in the cytotoxic mechanism of the toxin.

conclusionsThese results demonstrate that the catechins inhibit LtxA activity by altering its structure to prevent interaction with specific molecules present on the host cell surface. GENERAL SIGNIFICANCE: Galloylated catechins modify protein toxin structure, inhibiting the toxin from binding to the requisite molecules on the host cell surface.

Indexed as

Aggregatibacter actinomycetemcomitansBacterial ToxinsCatechinCell MembraneCell SurvivalCholesterolCircular DichroismExotoxinsHumansLeukocytesMembrane FluidityMicroscopy, ConfocalPeriodontitisProtein Structure, SecondarySurface Plasmon ResonanceTHP-1 CellsBacterial ToxinsCatechinCholesterolExotoxinsleukotoxinAggregatibacter actinomycetemcomitansBacterial toxinCatechinsleukotoxinRTX toxin

Identifiers

PMID30342156
PMCPMC6235716
OpenAlexW2897396243

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.